4//SEC Filing
Lucchino David L. 4
Accession 0001127602-23-022901
CIK 0001703647other
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 8:01 AM ET
Size
7.0 KB
Accession
0001127602-23-022901
Insider Transaction Report
Form 4
Lucchino David L.
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2023-08-16$0.65/sh−2,895$1,882→ 642,399 total - Sale
Common Stock
2023-08-17$0.63/sh−2,733$1,722→ 639,666 total
Footnotes (3)
- [F1]Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person.
- [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.631 to $0.680. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- [F3]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.611 to $0.631. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
Documents
Issuer
Frequency Therapeutics, Inc.
CIK 0001703647
Entity typeother
Related Parties
1- filerCIK 0001785288
Filing Metadata
- Form type
- 4
- Filed
- Aug 17, 8:00 PM ET
- Accepted
- Aug 18, 8:01 AM ET
- Size
- 7.0 KB